Medindia

X

Boston Scientific Announces FDA Approval and U.S. Launch of PROMUS® 2.25 mm Everolimus-Eluting Coronary Stent System

Wednesday, May 25, 2011 General News J E 4
Advertisement
Boston Scientific becomes the first and only company to offer two distinct drug-eluting stents to treat small vessels

CONTACT:

Erik Kopp

508-650-8660 (office)

Media Relations

Boston Scientific Corporation

erik.kopp@bsci.com

Sean Wirtjes

508-652-5305 (office)

Investor Relations

Boston Scientific Corporation

investor_relations@bsci.com

Advertisement


Advertisement

You May Also Like

Advertisement
View All

Post your Comments

Comments should be on the topic and should not be abusive. The editorial team reserves the right to review and moderate the comments posted on the site.
User Avatar
* Your comment can be maximum of 2500 characters
I agree to the terms and conditions
s
Auxilium Pharmaceuticals to Present at the Jefferi...
S
Aldrich Materials Science Endows New Materials Res...